Mabnus Biotech is committed to addressing challenges in the industry related to the development of functional active proteins and high-quality, high-throughput antibodies. Leveraging two core platforms: the mammalian cell protein expression platform and the B-cell antibody development platform, the company is dedicated to providing one-stop antibody development services to scientific research institutions, diagnostic and pharmaceutical companies.
The company's research and development team has decades of experience in protein expression and antibody development, leading technology reserves and well-equipped platforms. It excels in areas such as the expression of functional active proteins, the development of recombinant rabbit monoclonal antibodies, recombinant antibody expression and stable cell line construction, showcasing a leading technological capability. The company is devoted to providing technical services, including prokaryotic expression, eukaryotic expression, polyclonal antibody preparation, monoclonal antibody preparation, neutralizing antibody preparation, antibody drug production, recombinant antibody production, hybridoma cell culture, antibody labeling and Elisa kit development, to research and industry users.
We have successfully developed custom proteins from various species, including humans, rats, mice, viruses and zebrafish. It possesses top-notch protein expression technology and core competitive new-generation recombinant rabbit monoclonal antibody development technology. The company can develop recombinant active proteins, rabbit polyclonal antibodies, mouse monoclonal antibodies, large-scale culture and production of hybridoma cells, recombinant rabbit monoclonal antibody development, neutralizing antibody development, recombinant antibody production, antibody sequencing, antibody labeling and kit development, showcasing advanced research and production capabilities.
With the development philosophy of "Practicality, Sincerity, Diligence and Self-discipline," Mabnus Biotechnology remains true to its original aspiration, committed to providing high-quality products and technical services for life science research.
Driven by the vision of "Independent research and development, continuous innovation" the company strives step by step towards becoming an internationally leading platform for antibody research and industrialized production.